S&P 500

5.277,51

0,80%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY)
Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY) News

ENZY

ENZYMOTEC LTD. (ENZY)

Enzymotec Ltd. - Ordinary Shares (delisted)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ENZY

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
19/02/2019	08h00	GlobeNewswire	Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
30/01/2019	08h30	GlobeNewswire	Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
25/01/2019	08h30	GlobeNewswire	Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
10/12/2018	14h30	GlobeNewswire	Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
02/12/2018	18h00	GlobeNewswire	Enzymatica AB: Enzymatica raises SEK 98.7 million in completed share issue	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
12/11/2018	13h00	GlobeNewswire	Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
05/11/2018	11h15	GlobeNewswire	Enzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
02/11/2018	09h00	GlobeNewswire	Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
31/10/2018	08h30	GlobeNewswire	Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
18/10/2018	08h30	GlobeNewswire	Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
18/10/2018	08h00	GlobeNewswire	Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
18/10/2018	07h30	GlobeNewswire	Enzymatica AB: Enzymatica signs agreement for the Japanese market	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
01/10/2018	08h30	GlobeNewswire	Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold sympto...	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
29/08/2018	08h30	GlobeNewswire	Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
31/07/2018	13h00	GlobeNewswire	Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
17/07/2018	08h30	GlobeNewswire	Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
16/07/2018	08h30	GlobeNewswire	Enzymatica AB: Court ruling put restrictions on marketing of Enzymatica's cold spray in Germany	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
07/06/2018	08h30	GlobeNewswire	Enzymatica AB: Enzymatica secures funding for operations	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
22/05/2018	08h30	GlobeNewswire	Enzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
26/04/2018	15h30	GlobeNewswire	Enzymatica AB: Bulletin from annual general meeting 2018 in Enzymatica AB (publ)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
26/04/2018	08h30	GlobeNewswire	Enzymatica AB: Continued growth during the first quarter	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
11/04/2018	08h45	GlobeNewswire	Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
09/04/2018	11h30	GlobeNewswire	Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
28/03/2018	08h30	GlobeNewswire	Enzymatica AB: Enzymatica - publication of the annual report 2017	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
21/03/2018	13h00	GlobeNewswire	Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
14/02/2018	08h00	GlobeNewswire	Enzymatica AB: Strong growth and international breakthrough in 2017	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
13/02/2018	12h15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
13/02/2018	12h14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
31/01/2018	15h22	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)
22/01/2018	14h55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ENZY	Enzymotec Ltd. - Ordinary Shares (delisted)